Ten years of fingolimod in multiple sclerosis: Who will benefit from it? Insights from a large real-world cohort study

Affiliation auteurs!!!! Error affiliation !!!!
TitreTen years of fingolimod in multiple sclerosis: Who will benefit from it? Insights from a large real-world cohort study
Type de publicationJournal Article
Year of Publication2021
AuteursGauer L., Bigaut K., Berger E., Debouverie M., Moreau T., De Seze J.
JournalMULTIPLE SCLEROSIS JOURNAL
Volume27
Pagination613-614
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN1352-4585